Compare ARK Genomic Revolution ETF (ARKG) vs Atomera Incorporated (ATOM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Atomera Incorporated — how do they compare? ARK Genomic Revolution ETF trades at $41, while Atomera Incorporated trades at $6.69 (market cap $256.50M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Atomera Incorporated nearer its low. Which is the better fit depends on your goals.
| ARKG | ATOM | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $12.11 |
52-Week Low | $23.09 | $1.99 |
Market Cap | — | $256.50M |
Enterprise Value | — | $216.71M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
ATOM trades at $6.63, down 2.93% with bearish technical signals. The company shows severe financial strain with negative gross profit margin of -520.83% and net income margin of -29,219.44% for 2025. Recent earnings misses and negative cash flow highlight operational challenges, though analyst consensus remains 100% buy rating based on technology licensing potential in semiconductor materials.
Outlook remains speculative with significant execution risk. The company's GaN-on-Silicon technology partnerships with Synopsys offer potential upside, but current financial metrics and consistent losses warrant caution. Investment opportunity exists only for risk-tolerant investors betting on technology adoption breakthroughs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Atomera Incorporated
Atomera is a semiconductor materials engineering company. Its Mears Silicon Technology (MST) is a patented thin film that enhances transistor performance, power efficiency, and cost for global chip manufacturers.
Read more on ATOM →
